AzTrials
AzTrials

Fetal HypoxiaNCT03930277

Intra-uterine Fetal Brain Activity Monitoring.

An observational study of Fetal Hypoxia, run by Rambam Health Care Campus.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Fetal cardiac monitoring is used during labor. Fetal decelerations may imply fetal hypoxia and distress. Brain activity monitoring is not used to evaluate fetal distress during labor. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Fetal Hypoxia
What is being tested?
Electroencephalogram
How many people
20 participants
Where
No sites listed yet
Study dates
31 Dec 2022to 1 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Adult

Study population: Pregannt women during the 2nd stage of labor at full dilatation.

Who may be able to join

  • Vaginal delivery course.
  • Patient with epidural anesthesia.
  • Continous fetal heart-rate monitoring.
  • Singleton pregnancy.
  • Term pregnancy.

Who cannot join

  • Suspected Chorioamnionitis.
  • No epidural anesthesia.
  • Multiple pregnancy.
  • Fetal abnormality with emphasis on brain abnormalities.
  • Preeclampsia.
  • Patients refusing continous fetal heart-rate monitoring.
Show all 9Show fewer
  • Patients in need of a scalp electrode for fetal monitoring.
  • Patients that received Dolestine during labor.
  • Patients with Hepatitis B, Hepatitis C and HIV carriers or any other vertically transmitted pathogenic agent.

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Using a New EEG Based Algorithm for Intra-uterine Fetal Brain Monitoring.

Fetal cardiac monitoring is used during labor. Fetal decelerations may imply fetal hypoxia and distress. Brain activity monitoring is not used to evaluate fetal distress during labor. In this study the investigators intend to use an EEG based algorithm to evaluate and monitor fetal brain activity during the 2nd stage of labor.

Read the detailed description

Fetal heart rate (FHR) monitoring is commonly used in order to reduce fetal intrapartum asphyxia or any associated long-term disabilities. The electronic fetal monitoring (EFM) was first described by Hon and others during the 1960s (1) (2) and introduced into clinical practice before any clear evidence of benefits had been demonstrated.

The EFM records the fetal heart rate, and characteristics such as baseline, accelerations, decelerations and variability are constantly evaluated in order to assess the hypoxic condition of the fetus and to identify fetal distress.

Nevertheless, most of the studies (3-5) demonstrated that abnormal patterns of the fetal heart rate are of low predictive value for intrapartum fetal hypoxia or metabolic acidosis. Among high-risk pregnant woman, the probability of fetal metabolic acidosis in the presence of repeated, variable decelerations is 25%, and 48% in the presence of late decelerations (6). According to the Cochrane review (7) EFM didn't decrease the rates of cerebral palsy (CP), asphyxias complications or perinatal morbidity. The positive predictive value of non-reassuring FHR patterns for the prediction of CP among singleton newborns with birth weight of 2500 grams or more is only 0.14% (8).

Hypoperfusion to a certain brain areas involves the rapid loss of brain function due to disturbances in brain blood supply. EEG shows typical changes in brain ischemia. These changes include: attenuation of faster waves, particularly in the beta and alpha frequency bands; enhancement of slower waves, mainly in the delta frequency band; regional attenuation without delta enhancement (RAWOD) and reduction of variability in the EEG signal (9). However, reaching effective sensitivity and specificity in immediate brain ischemia detection on the basis of EEG changes is still considered a challenge, as it depends on the presence of a skilled expert in neurophysiology to analyses raw EEG data in real-time.

The investigators developed a unique platform algorithm, which analyses EEG data, and recognizes patients suffering from brain ischemia (stroke), based on the phenomena of interhemispheric decreased synchronization. Interhemispheric synchronization is the measure of correlation in EEG activity between ipsilateral and contralateral hemispheres, where values range between 1 (complete synchronization) and 0 (no synchronization). Increased synchronization means greater correlation between related ipsilateral and contralateral activities and vice versa for decreased synchronization. Normal brains should have a high correlation/ synchronization. Once brain ischemia occurs and the hemisphere is damaged, the interhemispheric synchronization decreases. In a recent study, we have shown the decrease in synchronization when a certain part of the brain is anaesthetized, causing a lesion similar to brain ischemia, and the recovery of synchronization, when the anesthesia recovered2. In another study, the investigators have tested the reliability of the algorithm in patients undergoing mechanical thrombectomy for acute stroke. In the study patients with acute stroke admitted to neuro angio intervention undergone short EEG test for 5 minutes. At the end of the procedure patients underwent a second short EEG test. In the test the interhemispheric synchronization were analyzed. It was shown that patients admitted to the neuro-angio intervention, who had brain tissue that might be salvable, had an average synchronization of 0.8. If the procedure succeeded and there was a clinical improvement - the synchronization remained high. If the procedure did not succeed, or succeed without clinical improvement, the synchronization decreased to an average of 0.65. Importantly, patients who were not candidates for neuro intervention, because they didn't have salvable brain, their index of synchronization was low to begin with (figure 1a and 1b). This preliminary assay proves the ability of the synchronization index to detect brain hypoperfusion that occurs, for example, in stroke.

The objective of this proof of concept study is to test whether there is a correlation between the EEG index of interhemispheric synchronization, to the umbilical PH of the newborn and to the gold standard fetal heart rate monitor.

Conditions
Fetal Hypoxia
Being tested
Electroencephalogram
Medical subject headings
Fetal Hypoxia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ElectroencephalogramDiagnostic test

    Electroencephalogram for fetal brain activity monitoring.

Study groups in NCT03930277
Study groupRoleWhat they receive
Pregnant women in labor.Pregnant women in labor during the 2nd stage of labor.
Receives: Diagnostic Test: Electroencephalogram

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Newborn blood gases

    Correlation between the EEG index of interhemispheric synchronization, to the umbilical PH of the newborn and to the gold standard fetal heart rate monitor.

    Measured: From the beginning of the 2nd stage of labor up to 5 minutes postpartum.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2019
  2. Study start31 Dec 2022 (estimated)
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion1 Mar 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03930277
Sponsor's protocol ID
0354-18-RMB
Status last verified
Apr 2022
First submitted
25 Apr 2019
Last updated
20 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Fetal Hypoxia, run by Rambam Health Care Campus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Roy Lauterbach, MD (972-52-9432416, r_lauterbach@rambam.health.gov.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Newborn blood gases (time frame: From the beginning of the 2nd stage of labor up to 5 minutes postpartum.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2022; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in